Cornelia Lass-Flörl Selected Research

Antifungal Agents

10/2021	The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.
12/2020	Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.
10/2020	Novel Antifungal Agents and Their Activity against Aspergillus Species.
1/2017	Changes in the epidemiological landscape of invasive mould infections and disease.
8/2016	In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.
6/2015	Antifungal drug resistance among Candida species: mechanisms and clinical impact.
12/2011	Triazole antifungal agents in invasive fungal infections: a comparative review.
11/2010	In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice?
5/2010	In vitro susceptibility testing in Aspergillus species: an update.
9/2009	Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cornelia Lass-Flörl Research Topics

Disease

55	Infections 12/2021 - 04/2002
36	Aspergillosis 01/2022 - 12/2003
31	Mycoses (Diseases, Fungus) 03/2022 - 10/2005
21	Invasive Fungal Infections 10/2022 - 04/2004
13	Neoplasms (Cancer) 06/2021 - 04/2004
11	Candidiasis (Moniliasis) 08/2022 - 02/2003
10	Invasive Candidiasis 08/2022 - 03/2009
9	Candidemia 04/2022 - 06/2009
7	Neutropenia 10/2022 - 12/2011
6	COVID-19 01/2022 - 01/2020
6	Pneumonia (Pneumonitis) 01/2021 - 09/2004
6	Inflammation (Inflammations) 01/2020 - 12/2013
5	Invasive Pulmonary Aspergillosis 09/2021 - 08/2012
4	Breakthrough Infections 01/2020 - 01/2012
4	Cystic Fibrosis (Mucoviscidosis) 01/2019 - 12/2013
4	Acquired Immunodeficiency Syndrome (AIDS) 06/2004 - 04/2002
3	Critical Illness (Critically Ill) 01/2021 - 09/2009
3	Pulmonary Aspergillosis 01/2021 - 10/2004
3	Mucormycosis 06/2020 - 01/2017
3	Hypoxia (Hypoxemia) 07/2019 - 12/2013
3	Coinfection 01/2019 - 03/2013
3	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 12/2008
3	Nervous System Diseases (Neurological Disorders) 06/2004 - 04/2002
2	Bacteremia 04/2022 - 02/2021
2	Sepsis (Septicemia) 06/2021 - 03/2015
2	Communicable Diseases (Infectious Diseases) 05/2020 - 09/2015
2	Thrombosis (Thrombus) 01/2020 - 10/2015
2	scedosporiosis 01/2017 - 11/2014
2	Leukemia 01/2017 - 10/2004
2	Cholangitis 09/2015 - 06/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022
1	Clostridium Infections 06/2021
1	Vulvovaginal Candidiasis 01/2021
1	Ascites 01/2021
1	Lung Injury 01/2021

Drug/Important Bio-Agent (IBA)

19	AzolesIBA 01/2021 - 04/2011
17	Complement System Proteins (Complement)IBA 02/2022 - 04/2002
14	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2022 - 12/2003
12	Voriconazole (Vfend)FDA LinkGeneric 10/2022 - 10/2004
12	Antifungal AgentsIBA 10/2021 - 09/2008
9	Fluconazole (Zonal)FDA LinkGeneric 01/2021 - 06/2009
8	galactomannanIBA 01/2022 - 10/2007
8	EchinocandinsIBA 01/2021 - 01/2011
7	TriazolesIBA 07/2018 - 12/2011
6	Biomarkers (Surrogate Marker)IBA 02/2021 - 12/2013
6	Caspofungin (Cancidas)FDA Link 01/2021 - 10/2005
6	liposomal amphotericin B FDA Link 12/2020 - 04/2005
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 08/2012
4	posaconazole FDA Link 01/2020 - 12/2011
4	EnzymesIBA 01/2019 - 10/2007
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2021 - 09/2014
3	Micafungin (FK463)FDA Link 01/2021 - 11/2014
3	AntigensIBA 10/2020 - 06/2018
3	IronIBA 12/2019 - 04/2010
3	Sodium Glutamate (Accent)IBA 09/2019 - 08/2012
2	Carbapenems (Carbapenem Antibiotics)IBA 04/2022 - 06/2021
2	AntibodiesIBA 01/2022 - 01/2019
2	MycotoxinsIBA 12/2021 - 09/2011
2	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2019
2	Fungal AntigensIBA 09/2021 - 01/2011
2	CytokinesIBA 02/2021 - 12/2019
2	Interleukin-17 (Interleukin 17)IBA 02/2021 - 01/2017
2	AnaphylatoxinsIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	Anidulafungin FDA Link 01/2021 - 09/2009
2	Cortisone FDA Link 01/2020 - 09/2014
2	galactosaminogalactanIBA 12/2019 - 10/2015
2	isavuconazoleIBA 01/2017 - 11/2013
2	Virulence Factors (Pathogenicity Factors)IBA 10/2015 - 09/2011
2	GliotoxinIBA 09/2011 - 04/2008
2	Fungal DNAIBA 01/2005 - 09/2004
1	ibrexafungerpIBA 08/2022
1	Investigational DrugsIBA 08/2022
1	Dihydrotachysterol (AT 10)IBA 04/2022
1	Glucose (Dextrose)FDA LinkGeneric 02/2022
1	BNT162 VaccineIBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Interferon Type IIBA 10/2021
1	InterferonsIBA 02/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2021
1	PTX3 proteinIBA 02/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Anaphylatoxin C5a ReceptorIBA 01/2021

Therapy/Procedure

30	Therapeutics 03/2022 - 12/2003
7	Hematopoietic Stem Cell Transplantation 01/2019 - 11/2008
6	Drug Therapy (Chemotherapy) 01/2017 - 12/2008
5	Stem Cell Transplantation 05/2020 - 10/2004
4	Catheters 06/2021 - 12/2005
4	Organ Transplantation 09/2015 - 04/2004
2	Central Venous Catheters 04/2022 - 01/2011
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2020 - 01/2019
2	Lung Transplantation 10/2019 - 03/2016
2	Liver Transplantation 09/2015 - 09/2009
2	Salvage Therapy 12/2011 - 03/2009
2	Transplantation 09/2009 - 10/2007
1	Induction Chemotherapy 10/2022